Global Monkeypox Market Overview:
Global Monkeypox Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Monkeypox Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Monkeypox involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Monkeypox Market:
The Monkeypox Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Monkeypox Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Monkeypox Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Monkeypox market has been segmented into:
Human-to-Human
Animal-to-Human
Environmental Exposure
By Application, Monkeypox market has been segmented into:
Mild
Moderate
Severe
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Monkeypox market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Monkeypox market.
Top Key Players Covered in Monkeypox market are:
Helsinn Healthcare
Merck Co
Sanofi
AstraZeneca
Vaccinex
ViralClear Pharmaceuticals
Pfizer
Moderna
Bavarian Nordic
Johnson Johnson
Emergent BioSolutions
Siga Technologies
Vaxart
GSK
Novavax
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Monkeypox Market Type
4.1 Monkeypox Market Snapshot and Growth Engine
4.2 Monkeypox Market Overview
4.3 Human-to-Human
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Human-to-Human: Geographic Segmentation Analysis
4.4 Animal-to-Human
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Animal-to-Human: Geographic Segmentation Analysis
4.5 Environmental Exposure
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Environmental Exposure: Geographic Segmentation Analysis
Chapter 5: Monkeypox Market Application
5.1 Monkeypox Market Snapshot and Growth Engine
5.2 Monkeypox Market Overview
5.3 Mild
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Mild: Geographic Segmentation Analysis
5.4 Moderate
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Moderate: Geographic Segmentation Analysis
5.5 Severe
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Severe: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Monkeypox Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 HELSINN HEALTHCARE
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 MERCK CO
6.4 SANOFI
6.5 ASTRAZENECA
6.6 VACCINEX
6.7 VIRALCLEAR PHARMACEUTICALS
6.8 PFIZER
6.9 MODERNA
6.10 BAVARIAN NORDIC
6.11 JOHNSON JOHNSON
6.12 EMERGENT BIOSOLUTIONS
6.13 SIGA TECHNOLOGIES
6.14 VAXART
6.15 GSK
6.16 NOVAVAX
Chapter 7: Global Monkeypox Market By Region
7.1 Overview
7.2. North America Monkeypox Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Human-to-Human
7.2.2.2 Animal-to-Human
7.2.2.3 Environmental Exposure
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Mild
7.2.3.2 Moderate
7.2.3.3 Severe
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Monkeypox Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Human-to-Human
7.3.2.2 Animal-to-Human
7.3.2.3 Environmental Exposure
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Mild
7.3.3.2 Moderate
7.3.3.3 Severe
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Monkeypox Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Human-to-Human
7.4.2.2 Animal-to-Human
7.4.2.3 Environmental Exposure
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Mild
7.4.3.2 Moderate
7.4.3.3 Severe
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Monkeypox Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Human-to-Human
7.5.2.2 Animal-to-Human
7.5.2.3 Environmental Exposure
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Mild
7.5.3.2 Moderate
7.5.3.3 Severe
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Monkeypox Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Human-to-Human
7.6.2.2 Animal-to-Human
7.6.2.3 Environmental Exposure
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Mild
7.6.3.2 Moderate
7.6.3.3 Severe
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Monkeypox Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Human-to-Human
7.7.2.2 Animal-to-Human
7.7.2.3 Environmental Exposure
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Mild
7.7.3.2 Moderate
7.7.3.3 Severe
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Monkeypox Scope:
|
Report Data
|
Monkeypox Market
|
|
Monkeypox Market Size in 2025
|
USD XX million
|
|
Monkeypox CAGR 2025 - 2032
|
XX%
|
|
Monkeypox Base Year
|
2024
|
|
Monkeypox Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Helsinn Healthcare, Merck Co, Sanofi, AstraZeneca, Vaccinex, ViralClear Pharmaceuticals, Pfizer, Moderna, Bavarian Nordic, Johnson Johnson, Emergent BioSolutions, Siga Technologies, Vaxart, GSK, Novavax.
|
|
Key Segments
|
By Type
Human-to-Human
Animal-to-Human
Environmental Exposure
By Applications
Mild
Moderate
Severe
|
